Active Surveillance for Intermediate Risk Prostate Cancer
This article reviews the role of active surveillance in managing intermediate-risk prostate cancer. It examines current evidence supporting the use of active surveillance for this patient group, considering factors like tumor characteristics, patient age, and life expectancy. The study suggests that active surveillance can be a reasonable alternative to aggressive